BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 7, 2004
View Archived Issues
Australia-Based Norwood Seeks IPO On London's AIM Exchange
An Australian company with a U.S. development partner is expecting to float on the Alternative Investment Market in London to raise £15 million (US$27.2 million). (BioWorld International)
Read More
Ablynx Completes EUR25M Series B Financing For Nanobody Platform
Read More
HIV Research Could Benefit From Immune System Model
Read More
Cilian, Evotec Neuroscience Reel In Venture Funding Totaling EUR30M
Read More
Ardana Signs New Zentaris Deal, Gains Global Rights To Teverelix
Read More
EU Finalizes Environmental Law That Could Leave Biotech Liable
Read More
Gastrotech Acquires Lilly Deal Through Purchase Of IP Assets
Read More
Other News To Note
Read More